A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with ...
A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.
The researchers found that individual SGLT-2 inhibitors showed similar cardiovascular effectiveness at clinically effective ...
The use of SGLT2 vs DPP4 inhibitors was linked to reduced cardiovascular and renal risks among patients with comorbid SLE and T2D.
GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. The age of type 2 ...
News Medical on MSN1d
Scientists design strategy for preventing cardiotoxic effects of anthracyclinesA team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with international partners, has designed a strategy for preventing the cardiotoxic ...
A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with ...
Researchers analyzed concentrations of microplastics in 91 brain tissue samples collected during autopsies in 2016 and 2024. The samples were from the frontal cortex, the brain region above and behind ...
A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new ...
What is ALPK2, and how can it help treat heart failure? Researchers have found that this heart-specific enzyme may prevent ...
CardioOncology, shows that administration of the SGLT2 inhibitor empagliflozin to pigs receiving anthracyclines preserves ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback